ペースメーカーの市場規模、シェア、成長分析：タイプ別、技術別、インプラント別、用途別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

世界のペースメーカー市場規模は2023年に46億7,000万米ドルと評価され、予測期間（2025-2032年）のCAGRは3.6%で、2024年の48億4,000万米ドルから2032年には64億2,000万米ドルに成長する見通しです。

心血管機器市場は、CVD有病率の上昇と関連する管理コスト、支持的な政府政策、リードレスやMRI安全モデルのような先進ペースメーカー技術に牽引され、大きな成長を遂げています。冠動脈性心疾患は依然として世界の死亡の主因であるため、心血管疾患の経済的負担は2030年までに1兆440億米ドルを超えると予測され、心臓ペーシングデバイスに対する差し迫った需要を生み出しています。COVID-19の大流行は、感染者の多くがCVD合併症を経験することから、患者の転帰を改善する必要性をさらに強めています。NHSやメディケアのような有利な償還制度が、市場へのアクセスを後押ししています。ボストンサイエンティフィックやメドトロニックをはじめとする業界大手各社は、遠隔監視システムなどの進歩を通じて精度と患者管理を強化し、償還制度に支えられた革新的なペースメーカーを発表しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術の進歩

ペースメーカー市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• MRI対応ペースメーカー
• 従来のペースメーカー

ペースメーカー市場規模：技術別& CAGR（2025-2032）

• 市場概要
• 単腔ペースメーカー
• デュアルチャンバーペースメーカー
• 両室/CRTペースメーカー

ペースメーカー市場規模：インプラント性& CAGR（2025-2032）

• 市場概要
• 埋め込み型ペースメーカー
  • 従来型
  • リードレス
• 外部ペースメーカー

ペースメーカー市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 徐脈
• 急性心筋梗塞
• 不整脈
• 心房細動
• 房室ブロック
• QT延長症候群
• 非うっ血性心不全
• その他

ペースメーカー市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 心臓クリニック
• 外来手術センター（ASC）
• その他

ペースメーカー市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Medtronic（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Biotronik SE & Co. KG（Germany）
• MicroPort Scientific Corporation（China）
• LivaNova PLC（UK）
• Lepu Medical Technology Co., Ltd.（China）
• Osypka AG（Germany）
• Oscor Inc.（USA）
• Pacetronix（India）
• Medico S.p.A.（Italy）
• Shree Pacetronix Ltd.（India）
• Cordis, a Cardinal Health company（USA）
• BIOTRONIK（Germany）
• ELA Medical（France）
• Vitatron（Netherlands）
• Guidant Corporation（USA）
• Intermedics Inc.（USA）

結論と推奨事項

Global Pacemakers Market size was valued at USD 4.67 billion in 2023 and is poised to grow from USD 4.84 billion in 2024 to USD 6.42 billion by 2032, growing at a CAGR of 3.6% during the forecast period (2025-2032).

The cardiovascular device market is experiencing significant growth, driven by rising CVD prevalence and related management costs, supportive government policies, and advanced pacemaker technologies like leadless and MRI-safe models. As coronary heart disease remains a leading cause of global mortality, the financial burden of cardiovascular diseases is projected to surpass USD 1,044 billion by 2030, creating a pressing demand for cardiac pacing devices. The COVID-19 pandemic has further intensified the need for improved patient outcomes as many infected individuals also experience CVD complications. Favorable reimbursement structures like the NHS and Medicare boost market accessibility. Industry leaders, including Boston Scientific and Medtronic, are launching innovative pacemakers supported by reimbursement plans, enhancing precision and patient management through advancements like remote monitoring systems.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pacemakers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pacemakers Market Segmental Analysis

Global Pacemakers Market is segmented by Type, Technology, Implantability, Application, End User and region. Based on Type, the market is segmented into MRI Compatible Pacemaker and Conventional Pacemaker. Based on Technology, the market is segmented into Single-chamber Pacemaker, Dual-chamber Pacemaker and Biventricular/CRT Pacemaker. Based on Implantability, the market is segmented into Implantable Pacemaker and External Pacemaker. Based on Application, the market is segmented into Bradycardia, Acute Myocardial Infarction, Arrhythmias, Atrial Fibrillation, Heart Block, Long QT Syndrome, Non-Congestive Heart Failure and Others. Based on End User, the market is segmented into Hospital, Cardiac Clinics, Ambulatory Surgical Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pacemakers Market

The global pacemakers market is significantly driven by the rising aging population, which contributes to a heightened prevalence of age-related cardiovascular conditions. As individuals grow older, they become more susceptible to various heart rhythm disorders, resulting in a greater need for pacemaker devices. This demographic shift not only amplifies the demand for innovative cardiac solutions but also propels advancements in pacemaker technology. Consequently, healthcare providers are increasingly focused on addressing the specific needs of elderly patients, which further fuels the expansion of the pacemakers market worldwide. Thus, the intersection of aging demographics and cardiovascular health creates a substantial growth opportunity in this sector.

Restraints in the Global Pacemakers Market

Restraints in the global pacemakers market are predominantly influenced by the high costs associated with these devices. The overall expenses encompass not only the price of the pacemaker itself but also the surgical procedures required for implantation and the subsequent follow-up care. Such financial burdens can restrict accessibility, particularly in developing regions where healthcare budgets are limited. This affordability challenge can significantly impede the growth of the pacemakers market, as potential patients may be unable to obtain the necessary treatments and medical interventions, ultimately affecting market expansion and the potential reach of pacemaker technologies.

Market Trends of the Global Pacemakers Market

The Global Pacemakers market is experiencing a significant trend driven by ongoing technological advancements that enhance device functionality and patient care. Manufacturers are increasingly integrating features such as remote monitoring, which allows healthcare providers to track patient data in real-time, alongside wireless connectivity that streamlines communication. Additionally, the introduction of MRI-compatible pacemakers and innovations aimed at extending battery life further bolster market appeal. These advancements not only improve device performance but also elevate patient convenience and safety, fueling market growth as healthcare systems seek devices that meet evolving clinical needs and improve outcomes for patients with cardiac conditions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Pacemakers Market Size by Type & CAGR (2025-2032)

• Market Overview
• MRI Compatible Pacemaker
• Conventional Pacemaker

Global Pacemakers Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Single-chamber Pacemaker
• Dual-chamber Pacemaker
• Biventricular/CRT Pacemaker

Global Pacemakers Market Size by Implantability & CAGR (2025-2032)

• Market Overview
• Implantable Pacemaker
  • Conventional
  • Leadless
• External Pacemaker

Global Pacemakers Market Size by Application & CAGR (2025-2032)

• Market Overview
• Bradycardia
• Acute Myocardial Infarction
• Arrhythmias
• Atrial Fibrillation
• Heart Block
• Long QT Syndrome
• Non-Congestive Heart Failure
• Others

Global Pacemakers Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital
• Cardiac Clinics
• Ambulatory Surgical Centers (ASCs)
• Others

Global Pacemakers Market Size & CAGR (2025-2032)

• North America (Type, Technology, Implantability, Application, End User)
  • US
  • Canada
• Europe (Type, Technology, Implantability, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Technology, Implantability, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Technology, Implantability, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Technology, Implantability, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osypka AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oscor Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacetronix (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medico S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shree Pacetronix Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cordis, a Cardinal Health company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ELA Medical (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitatron (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guidant Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intermedics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations